The utility of ultrasound surveillance of fluid and growth in obese women
- PMID: 24791732
- PMCID: PMC4214899
- DOI: 10.1016/j.ajog.2014.04.028
The utility of ultrasound surveillance of fluid and growth in obese women
Abstract
Objective: The purpose of this study was to evaluate the utility of ultrasound surveillance in obese women.
Study design: This is a retrospective cohort of all obese women who underwent sonography at a single center from 2005-2013. Inclusion criteria were body mass index ≥30 kg/m(2), singleton, ≥1 ultrasound scan performed at <20 weeks of gestation, and ≥1 ultrasound scan performed at ≥24 weeks of gestation. Pregnancies with medical complications, fetal anomalies, or preterm premature rupture of membranes were excluded. Outcomes that were considered were small for gestational age, large for gestational age (LGA), macrosomia, oligohydramnios, and polyhydramnios. We calculated the number needed to screen (NNS) and 95% confidence interval (CI) for scans that were performed during 3 gestational age ranges (24-31 weeks 6 days, 32-35 weeks 6 days, and ≥36 weeks).
Results: Two thousand two sonograms were performed in 1164 obese women at ≥24 weeks of gestation. Small for gestational age was diagnosed in 59 pregnancies (5.1%); 7 pregnancies (0.6%) were diagnosed at <32 weeks of gestation (NNS, 159; 95% CI, 69-490). LGA was diagnosed in 38 cases (3.3%); only 1 case was identified at <32 weeks of gestation and was not LGA at birth. For every 29 (95% CI, 19-46) scans performed at >36 weeks of gestation, 1 case of macrosomia was identified. Amniotic fluid abnormalities were diagnosed in 44 pregnancies (3.8%; oligohydramnios, 19; polyhydramnios, 25); 34.1% abnormalities were diagnosed at <32 weeks of gestation (NNS: oligohydramnios, 113; 95% CI, 55-282 for oligohydramnios; polyhydramnios, 100; 95% CI, 50-230). At ≥36 weeks of gestation, 7 (95% CI, 6-8) scans were needed to diagnose any fluid or growth abnormality.
Conclusion: In obese women without comorbidities, few sonographic diagnoses of amniotic fluid or fetal growth abnormalities are made at <32 weeks of gestation. Therefore, if a policy of serial sonographic surveillance is used, we suggest ultrasound scans for fluid and growth in obese women to begin at ≥32 weeks of gestation.
Keywords: amniotic fluid; fetal growth; obesity; surveillance; ultrasound.
Copyright © 2014 Elsevier Inc. All rights reserved.
Conflict of interest statement
DISCLOSURE: The authors report no conflict of interest.
References
-
- Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstetrics & Gynecology. 2004;103:219–224. - PubMed
-
- Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes.[see comment] New England Journal of Medicine. 1998;338:147–152. - PubMed
-
- Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. International Journal of Obesity & Related Metabolic Disorders: Journal of the International Association for the Study of Obesity. 2001;25:1175–1182. - PubMed
-
- Weiss JL, Malone FD, Emig D, et al. Obesity, obstetric complications and cesarean delivery rate--a population-based screening study. American Journal of Obstetrics & Gynecology. 2004;190:1091–1097. - PubMed
-
- Gardosi J, Francis A. Adverse pregnancy outcome and association with small for gestational age birthweight by customized and population-based percentiles. American journal of obstetrics and gynecology. 2009;201:28, e1–e8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
